Nucl Med Mol Imaging.  2022 Apr;56(2):102-104. 10.1007/s13139-021-00732-4.

[68 Ga]Ga-PSMA-11 Small Bowel Uptake in Crohn’s Disease: Revisiting the “Non-specificity” of PSMA Ligands

Affiliations
  • 1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India
  • 2Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Abstract

The rapidly evolving clinical utility of prostate-specific membrane antigen (PSMA) PET/CT as an imaging modality for prostate cancer (PCa) has brought to the forefront a multitude of non-prostatic diseases also exhibiting PSMA radioligand uptake. We report a case of a 71-year-old male with PCa who underwent PSMA PET/CT for recurrence evaluation. The scan demonstrated [68 Ga]Ga-PSMA-11 uptake in the distal ileum. Retrospective enquiry revealed that the patient was a known case of Crohn’s disease. This case highlights an uncommon finding of PSMA radioligand uptake in the distal small bowel (non-prostatic benign pathological uptake) in a patient with known Crohn’s disease, which may be misinterpreted in the evaluation of PCa.

Keyword

Prostate-specific membrane antigen (PSMA); Prostate cancer; PET/CT; Inflammatory bowel disease (IBD) ; Crohn’s disease
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr